Synthesis, Biological Evaluation, Molecular Docking and Kinetic Investigation of New 2,4,5‐Trisubstituted Imidazole Derivatives as Antidiabetic Agents

A series of novel 2,4,5‐trisubstituted imidazole motifs have been synthesized by a magnetically‐tuned halloysite‐supported sulfonic acid catalyst. The prepared supported sulfonic acid catalyst was well characterized by High‐resolution transmission electron microscopy (HR‐TEM), Scanning electron microscopy (SEM), Energy dispersive X‐rays spectroscopy (EDS), Fourier transform infrared (FTIR), X‐ray powder diffraction (XRD), Thermogravimetric analysis (TGA), Brunauer–Emmett–Teller (BET), and Vibrating–sample magnetometry (VSM) techniques; and compounds were confirmed by 1H, 13C‐Nuclear magnetic resonance (NMR) and High resolution mass spectrometry (HRMS) techniques. The purity of compounds was established by High performance liquid chromatography (HPLC). All the prepared compounds were screened for their in vitro antidiabetic activity by using α‐amylase and α‐glucosidase inhibition assay taking acarbose as a reference standard and were found to exhibit significant α‐amylase inhibitory potentials, whereas for α‐glucosidase inhibition, compounds were equipotent to the reference standard. Compound bearing ferrocene moiety was identified as the strongest α‐amylase inhibitor of the series with IC50=47.83±0.63 μM, a five‐fold more potency compared to acarbose (IC50 =269.39±0.29 μM). The presence of substituents in the second position of imidazole pharmacophore plays a key role in inhibitory activity. To find the possible binding interaction of compounds, in silico molecular docking study was performed.

[1]  M. Islam,et al.  α-Glucosidase and α-Amylase Inhibitory Potentials of Quinoline–1,3,4-oxadiazole Conjugates Bearing 1,2,3-Triazole with Antioxidant Activity, Kinetic Studies, and Computational Validation , 2022, Pharmaceuticals.

[2]  T. Mahmud,et al.  Complete biosynthetic pathway to the antidiabetic drug acarbose , 2022, Nature Communications.

[3]  M. Knorr,et al.  Diversity-Oriented Synthesis of Spiropyrrolo[1,2-a]isoquinoline Derivatives via Diastereoselective and Regiodivergent Three-Component 1,3-Dipolar Cycloaddition Reactions: In Vitro and in Vivo Evaluation of the Antidiabetic Activity of Rhodanine Analogues. , 2021, The Journal of organic chemistry.

[4]  O. Sanni,et al.  Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition. , 2021, Bioorganic chemistry.

[5]  S. Kaya,et al.  Novel antioxidant quinoxaline derivative: Synthesis, crystal structure, theoretical studies, antidiabetic activity and molecular docking study , 2021 .

[6]  Y. Mabkhot,et al.  Synthesis, crystal structure, hirshfeld surface analysis, DFT calculations, anti-diabetic activity and molecular docking studies of (E)-N’-(5-bromo-2-hydroxybenzylidene) isonicotinohydrazide , 2020, Journal of Molecular Structure.

[7]  M. Knorr,et al.  Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors. , 2020, Bioorganic chemistry.

[8]  A. Badshah,et al.  Assessing the biological potential of new symmetrical ferrocene based bisthiourea analogues. , 2020, Bioorganic chemistry.

[9]  B. Larijani,et al.  Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies , 2020, Molecular Diversity.

[10]  M. Akash,et al.  Taxifolin prevents postprandial hyperglycemia by regulating the activity of α‐amylase: Evidence from an in vivo and in silico studies , 2018, Journal of cellular biochemistry.

[11]  U. Ghali,et al.  Bioactivity-guided isolation of antidiabetic principles from the methanolic leaf extract ofBryophyllum pinnatum , 2018, Journal of Food Biochemistry.

[12]  M. Bordoloi,et al.  A Greener and Facile Synthesis of Imidazole and Dihydropyrimidine Derivatives under Solvent‐Free Condition Using Nature‐Derived Catalyst , 2017 .

[13]  T. Kirchner,et al.  Evaluation of anti-diabetic effect and gall bladder function with 2-thio-5-thiomethyl substituted imidazoles as TGR5 receptor agonists. , 2017, Bioorganic & medicinal chemistry letters.

[14]  Md. Ashraf,et al.  In search of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives. , 2017, Bioorganic chemistry.

[15]  M. Taher,et al.  Synthesis and characterization of magnetic halloysite-iron oxide nanocomposite and its application for naphthol green B removal , 2017 .

[16]  A. Tiwari,et al.  Synthesis, docking and ADMET studies of novel chalcone triazoles for anti-cancer and anti-diabetic activity. , 2015, European journal of medicinal chemistry.

[17]  M. Bajda,et al.  Organocatalyzed solvent free an efficient novel synthesis of 2,4,5-trisubstituted imidazoles for α-glucosidase inhibition to treat diabetes. , 2015, Bioorganic chemistry.

[18]  S. Tilve,et al.  Graphite catalyzed solvent free synthesis of dihydropyrimidin-2(1H)-ones/thiones and their antidiabetic activity. , 2014, Bioorganic & medicinal chemistry letters.

[19]  A. Sedrpoushan,et al.  Efficient Synthesis of 2,4,5-Triaryl-1H-Imidazoles from Aromatic Aldehydes with HMDS Catalyzed by N-Bromosaccharin (NBSa) , 2014 .

[20]  J. Medina-Franco,et al.  Synthesis of 2-{2-[(α/β-naphthalen-1-ylsulfonyl)amino]-1,3-thiazol-4-yl} acetamides with 11β-hydroxysteroid dehydrogenase inhibition and in combo antidiabetic activities. , 2014, European journal of medicinal chemistry.

[21]  I. Ogunwande,et al.  Modes of Inhibition of α-Amylase and α-Glucosidase by Aqueous Extract of Morinda lucida Benth Leaf , 2013, BioMed research international.

[22]  G. Oboh,et al.  Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. , 2013, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[23]  Jianhua Shen,et al.  Design, synthesis, and antidiabetic activity of 4-phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists. , 2012, Journal of medicinal chemistry.

[24]  A. Llebaria,et al.  A prospect for pyrrolidine iminosugars as antidiabetic α-glucosidase inhibitors. , 2012, Journal of medicinal chemistry.

[25]  D. Appleton,et al.  Flavonoids isolated from Syzygium aqueum leaf extract as potential antihyperglycaemic agents , 2012 .

[26]  Qiong Chen,et al.  Novel synthetic methods for N-cyano-1H-imidazole-4-carboxamides and their fungicidal activity. , 2012, Bioorganic & medicinal chemistry letters.

[27]  B. Narasimhan,et al.  Biological importance of imidazole nucleus in the new millennium , 2011, Medicinal Chemistry Research.

[28]  A. Teimouri,et al.  An efficient and one-pot synthesis of 2,4,5-trisubstituted and 1,2,4,5-tetrasubstituted imidazoles catalyzed via solid acid nano-catalyst , 2011 .

[29]  S. Ali.  Potassium ferro-cyanide trihydrate complex catalyzed one-pot synthesis of 2-phenylimidazo [4,5-f] [1,10] phenanthroline , 2011 .

[30]  P. Jia,et al.  Synthesis of Magnetic Ferriferrous Oxide/Halloysite Composite , 2011 .

[31]  S. Hsieh,et al.  Green fabrication of agar-conjugated Fe3O4 magnetic nanoparticles , 2010, Nanotechnology.

[32]  A. Zare,et al.  Catalyst-free one-pot four component synthesis of polysubstituted imidazoles in neutral ionic liquid 1-butyl-3-methylimidazolium bromide. , 2010, Journal of combinatorial chemistry.

[33]  J. Romero‐García,et al.  Biomimetic polymerization of aniline using hematin supported on halloysite nanotubes , 2010 .

[34]  Rangappa S. Keri,et al.  Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. , 2009, European journal of medicinal chemistry.

[35]  K. Constantine,et al.  Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity. , 2009, Journal of medicinal chemistry.

[36]  A. Reller,et al.  Study of Natural Halloysite from the Dragon Mine, Utah (USA) , 2009 .

[37]  J. Medina-Franco,et al.  Antidiabetic activity of N-(6-substituted-1,3-benzothiazol-2-yl)benzenesulfonamides. , 2008, Bioorganic & medicinal chemistry letters.

[38]  M. Fowler.  Microvascular and Macrovascular Complications of Diabetes , 2008, Clinical Diabetes.

[39]  G. Sharma,et al.  Efficient Room‐Temperature Synthesis of Tri‐ and Tetrasubstituted Imidazoles Catalyzed by ZrCl4 , 2006 .

[40]  Bruno Delvaux,et al.  Halloysite clay minerals – a review , 2005, Clay Minerals.

[41]  Jyoti R. Patel,et al.  Antidiabetic activity of passive nonsteroidal glucocorticoid receptor modulators. , 2005, Journal of medicinal chemistry.

[42]  K. Srinivasan,et al.  Room temperature ionic liquid promoted improved and rapid synthesis of 2,4,5-triaryl imidazoles from aryl aldehydes and 1,2-diketones or α-hydroxyketone , 2005 .

[43]  Ingrid Pettersson,et al.  Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity , 2002 .

[44]  J. Lombardino,et al.  Preparation and antiinflammatory activity of some nonacidic trisubstituted imidazoles. , 1974, Journal of medicinal chemistry.

[45]  S. Bhosale,et al.  Synthesis, crystal structure and antidiabetic activity of substituted (E)-3-(Benzo [d]thiazol-2-ylamino) phenylprop-2-en-1-one. , 2013, European journal of medicinal chemistry.